Kanwarpal Kahlon, MD, from Ronald Reagan UCLA Medical Center talks about the highlights from Myelodysplastic Syndrome (MDS) and nonmalignant hematology and also new drugs for MDS: Rigosertib, Luspatercept, Ibrutnib at MOASCs Spotlight On® Hematology in Huntington Beach.
Highlights from MDS and Nonmalignant Hematology – New drugs for MDS: Rigosertib, Luspatercept, Ibrutnib
